Experienced in Mycobacterium Avium Complex Infections

Vineet K. Ahuja

Aiims
New Delhi, DL, IN 
Experienced in Mycobacterium Avium Complex Infections
Aiims
New Delhi, DL, IN 
OverviewLocationsClinical Research

Overview

Vineet Ahuja practices in New Delhi, India. Mr. Ahuja is rated as an Experienced expert by MediFind in the treatment of Mycobacterium Avium Complex Infections. His top areas of expertise are Colitis, Viral Gastroenteritis, Malabsorption, Ileostomy, and Colonoscopy.

His clinical research consists of co-authoring 343 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Mycobacterium Avium Complex Infections.

Gender
Male

Locations

AIIMS
New Delhi, DL, India
Other Locations
Gorakhpur, MH, India
Delhi, DL, India
Ansari, UP 110029, India
Bhubaneshwar, OR, India
Jodhpur, JK, India
Hyderabad, TG, India
Patiala, PB, India
Chandigarh, CH, India

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients With Crohn's Disease
Enrollment Status: Active_not_recruiting
Publish Date: April 18, 2025
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active- Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 27, 2024
Intervention Type: Drug
Study Drugs: Mirikizumab, Ustekinumab
Study Phase: Phase 3
View 1 Less Clinical Trial

343 Total Publications

Genomic insights and functional adaptation of Mycobacterium intracellulare strains isolated from patients with inflammatory bowel disease.
Genomic insights and functional adaptation of Mycobacterium intracellulare strains isolated from patients with inflammatory bowel disease.
Journal: Microbiology spectrum
Published: October 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Ahuja's expertise for a condition
ConditionClose
View All 7 Elite Conditions
View All 8 Advanced Conditions
View All 53 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile